Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (24 ops.)
Latest filing published 24 Jul 2026 for GENESCO INC.
Filing timeline
BuySaleMatthew M. Bilunas
Insider track record
Disclosed buys
1
Disclosed sells
24
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -41.8%Entry US$48.21 · Close at T+365 US$28.06
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Matthew M. Bilunas: trading record in brief
Matthew M. Bilunas is Chief Financial Officer of Best Buy Co Inc (44 filings) and a Director of Genesco Inc (5), making 49 filings published between March 11, 2020 and July 24, 2026. The 24 sales total EUR 14,434,067, with a median of EUR 224,138; all are at Best Buy Co Inc, including the two largest: EUR 5,409,255 on December 11, 2024 and EUR 3,492,325 on March 24, 2025. The only purchase, EUR 22,696, is dated February 2, 2023 at Genesco Inc and makes up 4% of market trades.
The record also counts 21 grants and 3 option exercises.
The yearly volume goes from 10 filings in 2020 to 9 in 2021 and in 2022, 6 in 2023, 8 in 2024, 4 in 2025 and 3 in 2026. Three filings fall in the last twelve months, one of them a sale.
At Best Buy Co Inc, Kathleen Scarlett and Mathew Watson each have 19 trades within 30 days of a market trade by Bilunas, Todd G. Hartman 18, on the same side; Corie S. Barry 18, of which 16 on the same side. Filings are published a median of 2 days after the trade.
Companies and markets linked to Matthew M. Bilunas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations49 total
3,905 shares0Common StockSEC:0001193125-26-316051:0
29,857 shares0Common StockSEC:0001225208-26-003974:0
11,356 shares@ US$64.0190.0046% mcap9.4% of flowCommon StockSEC:0001225208-26-003974:1
5,393 shares0Common StockSEC:0000950170-25-091526:0
9,482 shares@ US$72.6479.4% of flowCommon StockSEC:0001225208-25-003639:0
51,000 shares@ US$74.2018.7% of flowCommon StockSEC:0001225208-25-003639:1
23,817 shares0Common StockSEC:0001225208-25-003547:0
20,116 shares@ US$51.655.3% of flowCommon StockSEC:0001225208-24-010811:1
3,999 shares@ US$87.911.8% of flowCommon StockSEC:0001225208-24-010811:2
65,167 shares@ US$87.4328.9% of flowCommon StockSEC:0001225208-24-010811:3
49,050 shares@ US$69.1147.9% of flowCommon StockSEC:0001225208-24-010811:0
4,540 shares0Common StockSEC:0000950170-24-079580:0
111 shares@ US$75.7610.1% of flowCommon StockSEC:0001225208-24-005133:0
8,258 shares@ US$81.7959.3% of flowCommon StockSEC:0001225208-24-004471:0
21,314 shares0Common StockSEC:0001225208-24-004454:0
4,658 shares0Common StockSEC:0001209191-23-039677:0
3,998 shares@ US$71.8234.0% of flowCommon StockSEC:0001225208-23-006500:0
7,951 shares0Common StockSEC:0001225208-23-006425:0
19,199 shares0Common StockSEC:0001225208-23-004180:0
7,181 shares@ US$77.952.8% of flowCommon StockSEC:0001225208-23-004180:1
510 shares@ US$49.01100.0% of flowCommon StockSEC:0001209191-23-006749:0
Canonical exit: 3 May 2023 (T+90)
890 shares@ US$79.091.1% of flowCommon StockSEC:0001225208-22-009798:0
6,065 shares@ US$80.6836.8% of flowCommon StockSEC:0001225208-22-007618:0
2,937 shares0Common StockSEC:0001225208-22-007435:1
2,879 shares0Common StockSEC:0001225208-22-007435:2
25 of 49 declarations
